Vgi Partners Pty Ltd buys $45.9 Million stake in Mead Johnson Nutrition CO (MJN)

Mead Johnson Nutrition CO (MJN) : Vgi Partners Pty Ltd scooped up 288,778 additional shares in Mead Johnson Nutrition CO during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 13, 2016. The investment management firm now holds a total of 548,502 shares of Mead Johnson Nutrition CO which is valued at $45.9 Million.Mead Johnson Nutrition CO makes up approximately 12.76% of Vgi Partners Pty Ltd’s portfolio.

Other Hedge Funds, Including , Ancora Advisors boosted its stake in MJN in the latest quarter, The investment management firm added 6,842 additional shares and now holds a total of 14,042 shares of Mead Johnson Nutrition CO which is valued at $1.2 Million. Mead Johnson Nutrition CO makes up approx 0.14% of Ancora Advisors’s portfolio.Mufg Americas Holdings Corp boosted its stake in MJN in the latest quarter, The investment management firm added 193 additional shares and now holds a total of 3,512 shares of Mead Johnson Nutrition CO which is valued at $293,990. Mead Johnson Nutrition CO makes up approx 0.01% of Mufg Americas Holdings Corp’s portfolio.Isthmus Partners boosted its stake in MJN in the latest quarter, The investment management firm added 5,393 additional shares and now holds a total of 45,096 shares of Mead Johnson Nutrition CO which is valued at $3.8 Million. Mead Johnson Nutrition CO makes up approx 1.25% of Isthmus Partners’s portfolio. Allegis Investment Advisors sold out all of its stake in MJN during the most recent quarter. The investment firm sold 376 shares of MJN which is valued $31,475.Hirtle Callaghan Co reduced its stake in MJN by selling 275 shares or 19.53% in the most recent quarter. The Hedge Fund company now holds 1,133 shares of MJN which is valued at $96,362. Mead Johnson Nutrition CO makes up approx 0.02% of Hirtle Callaghan Co’s portfolio.

Mead Johnson Nutrition CO opened for trading at $82.78 and hit $83.2 on the upside on Wednesday, eventually ending the session at $82.8, with a gain of 0.41% or 0.34 points. The heightened volatility saw the trading volume jump to 8,95,237 shares. Company has a market cap of $15,456 M.

On the company’s financial health, Mead Johnson Nutrition CO reported $0.87 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $0.84. The company had revenue of $962.10 million for the quarter, compared to analysts expectations of $954.99 million. The company’s revenue was down -12.1 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.09 EPS.

Many Wall Street Analysts have commented on Mead Johnson Nutrition CO. Mead Johnson Nutrition CO was Upgraded by Credit Suisse to ” Outperform” on Mar 16, 2016.

Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas children’s milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.

Leave a Reply

Mead Johnson Nutrition CO - Is it time to Sell?

Top Brokerage Firms are advising their investors on Mead Johnson Nutrition CO. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.